ROBERT JOHN RIGLIETTI

Personal Electronic Health Record

AI REPORTS

ABOUT AI REPORTS

The following AI Reports are generated by some of the latest, most powerful models at the time of report creation. These models utilize all of the data in this database, namely:

  • Appointment Logs
  • Food Logs
  • Lab Results
  • Medicine / Supplement Logs
  • Symptom Event Logs
  • Symptom Rating Logs
  • Medical Tests
  • Vital Logs
  • Sleep Logs

Each report runs through multiple passes of AI to ensure accuracy and pertinence. These reports help to guide conversation with real doctors, and provide some leads to explore.

AI REPORTS FOR DOCTORS

WEEKLY PERSONAL AI REPORTS

NameNotes
# Weekly Check-in Report (2026-02-03 to 2026-02-09) — Audited & Revised ## 1) Data availability (what was/wasn’t logged this week) **Present** - **Vitals (hourly/episodic):** rows exist for all dates 02-03 to 02-09, but **some days contain many rows with mostly-empty fields**, especially **02-06, 02-08, 02-09** (likely sync/off-wrist/placeholder-row effects; cannot assume true physiologic stability). - **Sleep log:** entries exist **02-03 through 02-09**, but **02-03 lacks objective sleep stage totals** (only “Good” rating) and **02-09 is blank**. - **Symptom ratings:** present **02-03 through 02-09**, but **02-07 to 02-09 are blank** (no symptom severities selected). - **Symptom events:** **one event** logged on **02-04** (moderate). **Absent (no records found this week)** - **Food log** (no rows) - **Labs** (no rows) - **Tests** (no rows) - **Appointments** (no rows) - **Medication/supplement dosing-by-day:** not present; the “Medicine / Supplements” table appears to be a longitudinal list. (Active items in the med list include **duloxetine**, **vitamin D3**, **methyl-B12**, **magnesium malate**, but **no within-week dosing changes are documentable**.) Because diet and daily dosing weren’t logged, within-week trigger analysis is limited. --- ## 2) High-level week summary (clinical) ### Main pattern: **Acute flare on 02-04** with partial improvement by 02-06 (based on ratings) - 02-04 shows **moderate fatigue + moderate body aches**, with **mild nausea**, **mild cough**, and **chest pain that is worse with deep breath** per the event description. - 02-05 shows persistent but milder symptoms including **brain fog/forgetfulness**, suggesting incomplete resolution and/or sleep-related amplification. ### Physiologic pattern: **High heart rates during active hours**, especially 02-05 midday and 02-07 evening - The data supports **episodes of high HR during periods with steps/stand time**, but **this week’s data alone cannot establish “POTS-like” physiology** because there are no orthostatic vitals and the HR elevation coincides with activity. ### Respiratory signal to verify: **Device SpO₂ lows on 02-07** - **SpO₂ 93%** appeared on two consecutive hours on 02-07 (device-derived), which should be treated as **“needs confirmation”** rather than confirmed hypoxemia—especially given earlier pleuritic symptoms on 02-04. --- ## 3) Symptoms (02-03 to 02-09) ### A) Symptom event(s) **02-04 09:30Z (moderate event):** - Description includes **chest pain when breathing deeply**, mild cough, diffuse body aches, fatigue, and minor queasiness after breakfast; hydrating and monitoring. **Clinical framing (hypotheses, not diagnoses):** - Could fit a **viral/URI-like episode**, **costochondritis/pleuritic irritation**, or **airway irritation**. The discriminating feature to clarify is whether pain was **reproducible to palpation** (more chest wall) vs purely **pleuritic**. ### B) Daily symptom ratings (only 02-03 to 02-06 contain actual ratings) - **02-04 (flare day):** fatigue **moderate (AM/MID)**; muscle aches **moderate (AM/MID)**; crash **mild** (AM/MID/PM); chest pain **mild** (AM/MID/PM); cough **mild** (AM/MID); nausea **mild** (AM). - **02-05:** persistent mild symptoms including fatigue, weakness, muscle aches, leg pain, plus **mild brain fog and forgetfulness** (AM/MID/PM). - **02-06:** **mild fatigue** persists with mild leg/neck pain; many other symptoms “none.”\ *Note:* calling this “near baseline” is **not justified** without a defined baseline. - **02-07 to 02-09:** entries exist but **all symptom fields are blank**, so we cannot evaluate late-week symptom burden or delayed post-exertional effects. --- ## 4) Sleep (objective logs) - **02-04:** Total asleep **8.2 h**, Sleep HRV avg **52 ms**. - **02-05:** Total asleep **3.475 h**, Sleep HRV avg **73 ms**. - **02-06:** Total asleep **7.517 h**, Sleep HRV avg **75 ms**. - **02-07:** Total asleep **7.817 h** (no sleep HRV recorded). - **02-08:** Total asleep **0.725 h**.\ **Important correction:** this may represent **only a captured sleep segment (nap/partial capture)** rather than confirmed near-total insomnia. - **02-09:** sleep row present but blank. **Hypothesis (plausible, not proven here):** short sleep (02-05 and possibly 02-08) may worsen symptom sensitivity and cardiovascular strain the next day, but this week lacks enough complete symptom + vitals coverage to demonstrate causality. --- ## 5) Vitals & activity signals (key observations, now fully cited for 02-04 and 02-05) ### A) Cardiovascular strain / tachycardia during activity **02-04 (flare day):** - 09:00Z: HR Avg **76.78**, HR Max **111**, Steps **332** - 10:00Z: HR Avg **89.15**, HR Max **115**, Steps **173** - 11:00Z: HR Avg **88.10**, HR Max **98**, Steps **179** - 12:00Z: HR Avg **84.75**, HR Max **90**, Steps **15** - 15:00Z: HR Avg **86.55**, HR Max **97**, Steps **25** - 16:00Z: HR Avg **85.46**, HR Max **109**, Steps **172** - 22:00Z: HR Avg **83.79**, HR Max **106**, Steps **278** **Revision vs Report v1:** the claim “avg HR \~80–89 with max up to \~115” is **supported** for 02-04, with a clear example at **10:00Z (Avg 89.15, Max 115)**. **02-05:** - 10:00Z: HR Avg **93.76**, HR Max **111**, Steps **215** - 11:00Z: HR Avg **95.55**, HR Max **113**, Steps **249** (HRV **14.39 ms** recorded) - 12:00Z: HR Avg **99.23**, HR Max **118**, Steps **128** - 13:00Z: HR Avg **98.06**, HR Max **125**, Steps **1173** - 16:00Z: HR Avg **91.28**, HR Max **104**, Steps **960** - 18:00Z: HR Avg **90.19**, HR Max **108**, Steps **1016** **Revision vs Report v1:** the claim “avg HR \~90–99 with max up to \~125” is **supported** for 02-05 (notably **13:00Z max 125**). **02-07 (evening high-HR block; key examples from available data excerpt):** - 20:00Z: HR Avg **114.82**, HR Max **127**, Stand **34 min**, Steps **721** - 21:00Z: HR Avg **109.11**, HR Max **128**, Steps **439** - 17:00Z: HR Avg **102.11**, HR Max **122**, Steps **513**\ (These coincide with high activity; “out of proportion” cannot be determined without context.) **Interpretation (cautious):** - These are **high HRs** during hours with **substantial steps/standing**. This could reflect normal exertional response, illness effects, sleep effects, hydration status, pain/anxiety, deconditioning, and/or dysautonomia. **This week alone does not establish POTS.** ### B) Oxygen saturation (device readings; confirm before interpretation) - **02-07 16:00Z:** SpO₂ **93%** - **02-07 17:00Z:** SpO₂ **93%** - **02-07 23:00Z:** SpO₂ **94%**\ Earlier week values are generally mid-90s to 99% when recorded. **Clinical note:** wearable SpO₂ can be artifact; however, repeated lows + a recent pleuritic episode justify **verification with a fingertip oximeter** if symptoms recur. --- ## 6) Correlations & hypotheses (clearly labeled) ### 1) 02-04 flare with pleuritic chest pain + cough + myalgias **Hypothesis:** mild respiratory infection or inflammatory episode vs costochondritis/pleuritic irritation.\ **What would support/refute:** fever/URI symptoms; positive viral testing; reproducible chest wall tenderness; recurrence pattern; clinician exam. ### 2) Sleep disruption as an amplifier **Hypothesis:** short sleep (02-05 objective; 02-08 unclear capture) could amplify fatigue, pain, cognitive symptoms, and elevate HR responses.\ **What would support/refute:** consistent sleep capture plus next-day symptom/HR comparisons vs baseline. ### 3) Exertion load and possible PEM (cannot evaluate this week) **Hypothesis:** 02-07’s high activity + high HR could trigger PEM 24–72h later.\ **Blocker:** symptom ratings are blank **02-08/02-09**, so PEM can’t be assessed. --- ## 7) Anomalies / items to verify 1. **SpO₂ 93% on 02-07 (two consecutive hours)** - Verify with fingertip pulse oximeter (resting, then after 1–3 minutes standing/walking). Record symptoms concurrently. 2. **Sleep log 02-08 showing only 0.725h** - Treat as “captured sleep segment only” until confirmed; check whether the main sleep episode failed to sync. 3. **Missing symptom ratings 02-07 to 02-09** - Major limitation; prevents assessing late-week symptoms and PEM. --- ## 8) Suggested clinician questions / next steps (to discuss with treating physician) 1. **Chest pain differential (02-04):** pleuritic vs reproducible; any shortness of breath, wheeze, fever; any recurrence since. 2. **SpO₂ confirmation plan:** have fingertip SpO₂ readings ever been <94% at rest? If yes, what symptoms accompanied it? 3. **If chest symptoms recur:** does clinician recommend **in-office vitals/pulse ox**, **lung exam**, and consider **ECG** ± **chest X-ray** based on exam? 4. **High HR with activity:** is this proportional to exertion? Would orthostatic vitals / active stand test be useful to quantify autonomic contribution? 5. **Sleep capture and stabilization:** is insomnia present or is this primarily device capture failure? What is the concrete sleep plan? --- ## 9) What to do next week (very specific tracking) - **Symptom ratings:** complete daily, including on “good days.” Add a note: **“PEM? (Y/N), onset delay, duration.”** - **If chest pain/cough recurs:** log - pain type (pleuritic vs reproducible), 0–10 severity, - fingertip **SpO₂** + **HR** at rest and after 2 minutes standing. - **Sleep:** if wearable misses the night, manually enter **bedtime/wake time** and whether you feel it was restorative. - **Minimal diet/fluids:** log caffeine/alcohol timing and approximate fluid + salt/electrolyte intake (even rough). --- **Bottom line:** The best-supported signal is a **multi-system flare on 02-04** (moderate fatigue + myalgias with pleuritic chest pain/cough features) with ongoing milder symptoms on 02-05 and mild residuals on 02-06. Vitals show **documented high HR during active hours** on 02-04, 02-05, and especially **02-07 evening**, plus **wearable SpO₂ lows (93%) on 02-07** that warrant **confirmation** if symptoms recur. Data gaps (food/dosing logs, missing symptom ratings 02-07 to 02-09, inconsistent sleep capture) limit conclusions about triggers and PEM.
# Weekly Check-in Report (2026-02-10 → 2026-02-16) ## 1) High-level summary This week is characterized by **significant sleep/circadian instability** (including **very short sleep recorded on 2/13: 2.70h** and a **short sleep segment recorded on 2/16: 1.59h**) and a **clear symptom flare peaking on 2/15** (fatigue/weakness/aches + lightheadedness, plus **cough** and **mild chest pain**). On **2/14**, vitals show **large activity bursts with elevated heart rate** (e.g., **2/14 17:00: 2,808 steps; HR avg 106; HR max 126**). The timing (**high exertion 2/14 → broader symptoms 2/15–2/16**) is **compatible with post-exertional symptom exacerbation/PEM**, but this is **not diagnostic** because competing contributors include **sleep restriction** (2/13) and a **possible short-lived respiratory/airway process** (cough + chest pain on 2/15). Two **low wearable SpO₂ readings** occurred (**91% on 2/12 05:00** and **90% on 2/14 09:00**). These may be artifact, but they warrant **confirmation** if they recur. No food logs, meds/supplements, labs, tests, appointments, or symptom-event notes were entered this week, which limits trigger attribution and clinical interpretation. --- ## 2) Data availability (what was/wasn’t logged) **Available** - **Vitals (hourly)**: available most days; **2/15 appears largely missing/blank** in the Vitals table. - **Sleep log**: entries for 2/10–2/16 (some entries appear incomplete/very short). - **Symptom ratings log**: present for 2/10–2/16 (**2/13 symptom row is empty**). **Not available / no records found** - **Food log**: none. - **Medicine/Supplements**: none. - **Labs**: none. - **Tests**: none. - **Appointments**: none. - **Symptom Events Log**: none. --- ## 3) Sleep & circadian pattern ### Sleep duration/quality (Sleep Log) - **2/10:** Total asleep **7.925h**; Sleep quality **Poor**; Sleep HRV avg **63 ms**; factor: **Bad Dreams** - **2/11:** Total asleep **6.133h**; Sleep HRV avg **42 ms** - **2/12:** Total asleep **6.157h**; Sleep quality **Poor**; Sleep HRV avg **73 ms** - **2/13:** Total asleep **2.701h** (Sleep Start 06:22Z → End 09:05Z); Sleep HRV avg not recorded - **2/14:** Total asleep **6.677h**; Sleep quality **Poor**; Sleep HRV avg **36 ms** - **2/15:** Sleep duration fields missing; Sleep quality set to **OK** - **2/16:** Total asleep **1.585h** (Sleep Start 08:50Z → End 10:25Z); Sleep quality **Good**; Sleep HRV avg **34 ms** ### Interpretation (evidence-grounded) - There is **objective evidence of very short sleep recorded** on **2/13** and **2/16**. However, the pattern also suggests **possible missing sleep capture** (device off/not worn or sleep not detected), especially for 2/16 and 2/15. - Sleep HRV averages were lower on **2/11 (42 ms)**, **2/14 (36 ms)**, and **2/16 (34 ms)**, but **comparability is limited** because some nights are extremely short (e.g., 2/16 only 1.6h recorded) and no baseline distribution is provided. **Key uncertainty to resolve next week:** For 2/16, was 08:50–10:25Z a **nap vs the only recorded portion** of a longer sleep? --- ## 4) Symptom ratings (daily) ### Early week (2/10–2/12): relatively mild - **2/10:** Mild AM fatigue; mild nausea AM; mild anxiety AM/mid/PM; mild leg pain PM. - **2/11:** Mild muscle weakness (AM and mid); mild muscle aches (mid and PM); mild headache (mid and PM). - **2/12:** Mild AM fatigue; mild lightheadedness AM; mild tremor PM; mild anxiety AM/mid/PM; mild forgetfulness AM. ### 2/13 - Symptom ratings row present but **all fields empty** (missing symptom data). ### 2/14: flare begins (neuromuscular/autonomic features) - Fatigue **mild** (AM/mid/PM) - Tremors **mild** (AM/mid/PM) - Muscle aches: **mild** (AM/mid), **moderate** (PM) - Leg pain **mild** (AM/mid/PM) - Insomnia (pre) **mild** - Depression (AM) **mild** ### 2/15: peak multi-system symptom day - Fatigue: **mild AM**, **moderate mid**, **mild PM** - Muscle weakness: **mild AM**, **moderate mid**, **mild PM** - “Crash”: **mild mid** - Lightheaded: **mild AM/mid/PM** - Muscle aches: **mild AM**, **moderate mid**, **mild PM** - Chest pain: **mild AM/mid/PM** - Cough: **moderate AM**, **mild mid**, **none PM** - Depression: **mild AM/mid/PM** ### 2/16: persistent but narrower symptom set - Fatigue **mild** (AM/mid/PM) - Muscle weakness **mild** (AM/mid/PM) - Muscle aches **mild** (AM/mid/PM) ### Interpretation (cautious) - The **2/14 → 2/15 pattern** (exertion + poor sleep context → next-day flare with fatigue/weakness/aches and “crash”) is **compatible with post-exertional symptom exacerbation/PEM**, but the presence of **cough + chest pain on 2/15** also supports considering a **brief respiratory/airway irritation or viral process** (not proven). - **Orthostatic intolerance** remains a **consideration** due to lightheadedness on 2/15, but this week lacks orthostatic HR/BP testing to support/deny it. --- ## 5) Vitals & activity highlights (2/10–2/16) ### Oxygen saturation (SpO₂) Notable low wearable readings: - **2/12 05:00:** SpO₂ **91%** - **2/14 09:00:** SpO₂ **90%** **Interpretation:** These are **wearable readings** and can be artifact, but if recurrent they warrant confirmation (especially given sleep disruption and the 2/15 cough/chest symptoms). ### Heart rate / exertion signals (selected high-load windows) **2/14** - **13:00:** Steps **1417**; Active Energy **81.58 kcal**; HR avg **97.76**; HR max **122** - **16:00:** Steps **1264**; Active Energy **57.23 kcal**; HR avg **84.93**; HR max **103** - **17:00:** Steps **2808**; Walking distance **1.426 mi**; Active Energy **129.22 kcal**; HR avg **106.16**; HR max **126**; Cardio recovery **47.53** **2/15** - Vitals are **largely missing/blank**, limiting physiologic interpretation on the day symptoms were worst. **2/16** - Several afternoon/evening hours show elevated HR averages during activity: - **15:00:** Steps **553**; HR avg **106.88**; HR max **119** - **16:00:** Steps **621**; HR avg **102.58**; HR max **118** - **19:00:** Steps **212**; HR avg **101.36**; HR max **118** - **20:00:** HR avg **104** (with low recorded activity; unclear if artifact vs stress vs delayed post-activity elevation) ### Interpretation (avoid overreach) - Activity/HR on **2/14** appears **substantial for this individual**, but without a rolling baseline we cannot formally label it “high” relative to their usual week. - The **2/16 elevated HR averages** occurred alongside step counts (i.e., likely exertional), so they do **not** demonstrate orthostatic tachycardia by themselves. --- ## 6) Key patterns & possible mechanisms (clearly labeled hypotheses) ### Pattern A: Exertion on 2/14 followed by worse symptoms 2/15–2/16 - **Evidence:** Major step bursts + high HR on 2/14; symptom peak on 2/15 with “crash,” fatigue/weakness/aches and lightheadedness; milder persistence on 2/16. - **Hypothesis (not proven):** **Post-exertional symptom exacerbation/PEM** contributed to the 2/15–2/16 symptom increase. - **Competing explanations:** sleep restriction (2/13), respiratory/airway process (cough 2/15), dehydration/electrolytes, stress. ### Pattern B: Intermittent low SpO₂ readings - **Evidence:** 90–91% readings on 2/12 and 2/14. - **Hypotheses:** sensor artifact; sleep-disordered breathing; transient hypoventilation; mild respiratory illness. - **What would support/deny:** repeated lows confirmed by a finger pulse-ox, especially when at rest and with good signal quality. ### Pattern C: Sleep instability as an amplifier - **Evidence:** very short sleep recorded 2/13 and 2/16; multiple “Poor” sleep ratings. - **Hypothesis:** Sleep loss/fragmentation lowered physiologic reserve, increasing vulnerability to symptom flares. --- ## 7) Confounders & uncertainties (what limits conclusions) - **No Food / Meds / Supplements logs:** cannot assess dietary triggers, stimulants, hydration/salt strategy, medication changes. - **No Symptom Events entries:** limits interpretation of chest pain and cough (timing, triggers, positionality, exertional relationship). - **2/15 vitals mostly missing:** prevents evaluating HR/SpO₂/RR during the worst symptom day. - **Timezone and sleep capture uncertainty:** some sleep entries may be **partial** (nap vs main sleep not clear). --- ## 8) What to do next week (very specific tracking instructions) 1. **Wearable completeness** - Aim for **continuous wear + sync daily**. - If the device is off/not worn, log a simple note: **“Device off: start–end time, reason.”** 2. **Sleep** - Add a binary label in Sleep Log notes (or a consistent text tag): **MAIN_SLEEP vs NAP**. - If you wake at night and resume sleep, add a brief note: **“split sleep”**. 3. **Orthostatic data (to evaluate OI/POTS)** - Do **NASA Lean Test or active stand** **3 mornings** (e.g., Tue/Thu/Sat): - Record **HR + BP** at **0, 2, 5, 10 minutes** (supine 5 min → stand/lean). - Record symptoms during test (lightheadedness, palpitations, nausea, tremor). 4. **Chest pain / cough events (if they recur)** - Create a **Symptom Event** entry each time: - onset time, duration, severity, relation to exertion, breathing, position, palpation tenderness, - any associated SOB, dizziness, sweating, radiation, - response to rest/hydration/meds. 5. **SpO₂ confirmation** - If wearable shows **≤92%**, immediately do a **finger pulse-ox** check (if available) and note: - awake/asleep, hand warmth, movement, nail polish, position. - Track whether lows cluster during sleep vs daytime. 6. **Minimum viable “inputs” logging** - Even if you don’t log full meals/supplements, record: - **caffeine**, **alcohol**, **new meds/supplements**, and **electrolytes/salt** with time. --- ## 9) Which doctors / specialties to consider (prioritized) + why 1. **Primary care (or ME/CFS-aware internist)** – to coordinate evaluation of chest pain episodes, intermittent low SpO₂, and to order baseline labs/tests if indicated. 2. **Sleep medicine** – given poor sleep quality ratings, irregular/possibly fragmented sleep capture, and low SpO₂ readings (rule out sleep-disordered breathing). 3. **Cardiology (or autonomic clinic if accessible)** – if chest pain recurs, if exertional intolerance persists, and to evaluate for orthostatic intolerance (tilt/NASA lean guidance) and rule out cardiac causes where appropriate. 4. **Pulmonology** (if SpO₂ lows persist/confirmed or cough recurs) – consider spirometry and further evaluation. --- ## 10) Doctor Discussion Topics (tests, questions, differential prompts) **A) Chest pain + cough day (2/15)** - “Given **mild chest pain all day** and **moderate AM cough**, what features would prompt **ECG / troponin / chest X-ray** vs conservative management?” - “Could this be musculoskeletal (costochondritis), reflux-related, asthma/bronchospasm, viral illness, or cardiac?” **B) Intermittent low SpO₂ (wearable)** - “I had SpO₂ readings **90–91%** (2/12 and 2/14). Should we confirm with **spot pulse oximetry** and consider a **home sleep apnea test** if lows recur?” **C) PEM-compatible pattern** - “The sequence **high activity (2/14) → symptom flare (2/15–2/16)** seems compatible with PEM. Can we define safe pacing parameters (HR cap) and how to track PEM objectively?” **D) Orthostatic intolerance** - “I had **lightheadedness all day 2/15**. Can we do **orthostatic vitals/NASA lean** and interpret results? If positive, what first-line measures (fluids/salt/compression/meds) fit my case?” --- ## Seek urgent care if… - **Chest pain** is new/severe, pressure-like, radiates to arm/jaw/back, occurs with **shortness of breath**, fainting, new weakness, or sweating. - **SpO₂ is persistently <92%** on a reliable device (finger pulse-ox) at rest, or you have blue lips, severe SOB, or confusion. - You develop **syncope** (fainting), new neurologic deficits, or rapidly worsening breathing symptoms. --- ### Bottom line The week shows **documented severe sleep restriction (2/13) and a short recorded sleep segment (2/16)**, followed by a **symptom flare peaking 2/15**. The timeline of **heavy exertion on 2/14** and worsened symptoms on **2/15–2/16** is **compatible with post-exertional symptom exacerbation**, but sleep disruption and a possible brief respiratory/airway episode are important competing contributors. Intermittent low wearable SpO₂ readings (90–91%) should be **confirmed** if they recur, especially in the context of poor sleep and cough/chest symptoms.
ME/CFS Genetics & Methylation Protocol Research Report - March 2026
Comprehensive research report covering: (1) Genes linked to ME/CFS from 2023-2025 literature including DecodeME GWAS, PrecisionLife, NIH intramural study, WASF3/mitochondrial findings, TRP channelopathy research; (2) Cross-reference of patient's 20 genetic variants against ME/CFS literature; (3) Evidence-based methylation support protocol for homozygous MTRR rs1801394 with ME/CFS; (4) SOD2 rs4880 antioxidant and mitochondrial support protocol. Key findings: 8 genome-wide significant loci from DecodeME (BTN2A2, OLFM4, RABGAP1L, FBXL4, CA10, ARFGEF2, DCC, CSE1L); HTR2A directly studied in CFS; ion channelopathy hypothesis strongly supported by patient's SCN1A, KCNQ1, TRPV4 variants; methylation trap mechanism from MTRR explains fading methylB12 response; riboflavin is critical MTRR cofactor often missed.

CONTACT:

Cell: (631) 793-2551

Email: robertjriglietti@tutanota.com

Made with Baserow